<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>eflornithine decreases putrescine — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>eflornithine</strong>
  <span class="pred">&mdash;decreases&rarr;</span>
  <strong>putrescine</strong>
</div>
<div class="entity-id">CHEBI:41948 &nbsp;&middot;&nbsp; HMDB:HMDB0001414</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 118.50<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 10.0 (Physical) &times; log&#8322;(1+1) = 10.00<br>Incoming citations: 18 &rarr; score 118.50</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1371/journal.pntd.0001618">10.1371/journal.pntd.0001618</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS459">MTBLS459</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 18 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:100px"></span><span>12</span><span class="cite-subtotal">&middot; +91.50</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">neopterin — distinguishes → Human African Trypanosomiasis stage 1 vs stage 2</span><span class="cite-claim-weight">+10.00</span><a href="../claim/998db00a6923d4a0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">5-hydroxytryptophan — distinguishes → Human African Trypanosomiasis stage 1 vs advanced stage 2</span><span class="cite-claim-weight">+10.00</span><a href="../claim/7994f1dd2e5ff451.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">neopterin — is_biomarker_for → Human African Trypanosomiasis stage 2</span><span class="cite-claim-weight">+10.00</span><a href="../claim/9e7446791e7c6ea6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">5-hydroxytryptophan — is_biomarker_for → Human African Trypanosomiasis</span><span class="cite-claim-weight">+10.00</span><a href="../claim/777ba78c93f20e63.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">CSF metabolite panel (11 metabolites) — distinguishes → Human African Trypanosomiasis stage 1 vs advanced stage 2</span><span class="cite-claim-weight">+10.00</span><a href="../claim/2c1f836c64e7341d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">5-hydroxytryptophan — correlates_with → somnolence (sleeping sickness)</span><span class="cite-claim-weight">+10.00</span><a href="../claim/6e8a32886021a020.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TbALDH3 — activates → benzaldehyde benzoxaborole metabolites</span><span class="cite-claim-weight">+0.50</span><a href="../claim/4a16ccb601c1e517.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">benzoxaborole methylamine pro-drugs — is_metabolite_of → benzaldehyde benzoxaborole intermediates</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bfd1af77b001ddb5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">benzaldehyde benzoxaborole intermediates — is_metabolite_of → carboxylate benzoxaborole metabolites</span><span class="cite-claim-weight">+0.50</span><a href="../claim/895a7cda3f25f882.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidised bisabolane sesquiterpene — inhibits → Leishmania mexicana</span><span class="cite-claim-weight">+10.00</span><a href="../claim/1f696e544f57144f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oxidised bisabolane sesquiterpene — causes → metabolic disruption in Leishmania mexicana</span><span class="cite-claim-weight">+10.00</span><a href="../claim/bb1e4dde92d90f1e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Compound 2 — inhibits → Staphylococcus aureus</span><span class="cite-claim-weight">+10.00</span><a href="../claim/0a32b55856c55d7f.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:17px"></span><span>2</span><span class="cite-subtotal">&middot; +8.40</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">4-aminomethylphenoxy-benzoxaboroles — treats → Human African Trypanosomiasis</span><span class="cite-claim-weight">+0.40</span><a href="../claim/b84497dde6ff7d21.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Compound 2 analogues — distinguishes → mode of action from known antibacterial compounds</span><span class="cite-claim-weight">+8.00</span><a href="../claim/008c6edbf66853f9.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:8px"></span><span>1</span><span class="cite-subtotal">&middot; +12.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">plasma metabolite panel — distinguishes → Human African Trypanosomiasis (diseased vs control)</span><span class="cite-claim-weight">+12.00</span><a href="../claim/139fab17aae198a0.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:25px"></span><span>3</span><span class="cite-subtotal">&middot; +6.60</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">semicarbazide-sensitive amine oxidase — activates → 4-aminomethylphenoxy-benzoxaboroles</span><span class="cite-claim-weight">+0.30</span><a href="../claim/b496e2cda74e3dba.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">carboxylate benzoxaborole metabolites — inhibits → Trypanosoma brucei</span><span class="cite-claim-weight">+0.30</span><a href="../claim/28a3a63655113a6a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Leishmania mexicana — causes → cutaneous leishmaniasis</span><span class="cite-claim-weight">+6.00</span><a href="../claim/5aeb79307d41c4e4.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>a9095ec4c05af73d</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:41948">CHEBI:41948</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/HMDB:HMDB0001414">HMDB:HMDB0001414</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
